PCBL Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 15, 2025, 8:49 pm

Quick Insight

PCBL Ltd, a Carbon Black company, currently trades at a price of 385 with a market capitalization of 14,534 Cr. The stock's P/E stands at 35.3, indicating a premium valuation, while ROE and ROCE are at 12.5% and 11.8% respectively. With a healthy operating profit margin of 15% and a net profit of 435 Cr, the company shows stability. The shareholder structure reveals strong promoter holding at 51.41%, with FIIs at 5.24% and DIIs at 6.70%. PCBL Ltd's reserves are at 3,660 Cr, supported by borrowings of ₹5,571 Cr. The company's P/BV ratio of 3.12x and ICR of 5.94x suggest a mixed outlook. Overall, PCBL Ltd appears to be a steady performer with a solid financial base, though its valuation metrics warrant further scrutiny.

Competitors of PCBL Ltd

All Competitor Stocks of PCBL Ltd

Quarterly Result

Last Updated: August 1, 2025, 3:30 pm

Below is a detailed analysis of the quarterly data for PCBL Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 2,114.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,087.00 Cr. (Mar 2025) to 2,114.00 Cr., marking an increase of 27.00 Cr..
• For Expenses, as of Jun 2025, the value is 1,795.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,790.00 Cr. (Mar 2025) to 1,795.00 Cr., marking an increase of 5.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 319.00 Cr.. The value appears strong and on an upward trend. It has increased from 298.00 Cr. (Mar 2025) to 319.00 Cr., marking an increase of 21.00 Cr..
• For OPM %, as of Jun 2025, the value is 15.00%. The value appears strong and on an upward trend. It has increased from 14.00% (Mar 2025) to 15.00%, marking an increase of 1.00%.
• For Other Income, as of Jun 2025, the value is 6.00 Cr.. The value appears to be declining and may need further review. It has decreased from 20.00 Cr. (Mar 2025) to 6.00 Cr., marking a decrease of 14.00 Cr..
• For Interest, as of Jun 2025, the value is 112.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 103.00 Cr. (Mar 2025) to 112.00 Cr., marking an increase of 9.00 Cr..
• For Depreciation, as of Jun 2025, the value is 92.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 88.00 Cr. (Mar 2025) to 92.00 Cr., marking an increase of 4.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 120.00 Cr.. The value appears to be declining and may need further review. It has decreased from 126.00 Cr. (Mar 2025) to 120.00 Cr., marking a decrease of 6.00 Cr..
• For Tax %, as of Jun 2025, the value is 22.00%. The value appears to be increasing, which may not be favorable. It has increased from 21.00% (Mar 2025) to 22.00%, marking an increase of 1.00%.
• For Net Profit, as of Jun 2025, the value is 94.00 Cr.. The value appears to be declining and may need further review. It has decreased from 100.00 Cr. (Mar 2025) to 94.00 Cr., marking a decrease of 6.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 2.49. The value appears to be declining and may need further review. It has decreased from 2.65 (Mar 2025) to 2.49, marking a decrease of 0.16.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: May 3, 2025, 1:36 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: May 13, 2025, 2:56 pm

Below is a detailed analysis of the balance sheet data for PCBL Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 38.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 38.00 Cr..
• For Reserves, as of Mar 2025, the value is 3,660.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,209.00 Cr. (Mar 2024) to 3,660.00 Cr., marking an increase of 451.00 Cr..
• For Borrowings, as of Mar 2025, the value is 5,571.00 Cr.. The value appears to be increasing, which may not be favorable. However, Borrowings exceed Reserves, which may signal higher financial risk. It has increased from 4,983.00 Cr. (Mar 2024) to 5,571.00 Cr., marking an increase of 588.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 2,453.00 Cr.. The value appears to be improving (decreasing). It has decreased from 3,066.00 Cr. (Mar 2024) to 2,453.00 Cr., marking a decrease of 613.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 11,722.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 11,295.00 Cr. (Mar 2024) to 11,722.00 Cr., marking an increase of 427.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 6,597.00 Cr.. The value appears to be declining and may need further review. It has decreased from 6,892.00 Cr. (Mar 2024) to 6,597.00 Cr., marking a decrease of 295.00 Cr..
• For CWIP, as of Mar 2025, the value is 730.00 Cr.. The value appears strong and on an upward trend. It has increased from 433.00 Cr. (Mar 2024) to 730.00 Cr., marking an increase of 297.00 Cr..
• For Investments, as of Mar 2025, the value is 516.00 Cr.. The value appears strong and on an upward trend. It has increased from 433.00 Cr. (Mar 2024) to 516.00 Cr., marking an increase of 83.00 Cr..
• For Other Assets, as of Mar 2025, the value is 3,879.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,537.00 Cr. (Mar 2024) to 3,879.00 Cr., marking an increase of 342.00 Cr..
• For Total Assets, as of Mar 2025, the value is 11,722.00 Cr.. The value appears strong and on an upward trend. It has increased from 11,295.00 Cr. (Mar 2024) to 11,722.00 Cr., marking an increase of 427.00 Cr..

However, the Borrowings (5,571.00 Cr.) are higher than the Reserves (3,660.00 Cr.), which may signal higher financial risk.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for PCBL Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 24, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 1.00.
• For Basic EPS (Rs.), as of Mar 24, the value is 13.00. This value is within the healthy range. It has increased from 11.70 (Mar 23) to 13.00, marking an increase of 1.30.
• For Diluted EPS (Rs.), as of Mar 24, the value is 13.00. This value is within the healthy range. It has increased from 11.70 (Mar 23) to 13.00, marking an increase of 1.30.
• For Cash EPS (Rs.), as of Mar 24, the value is 18.76. This value is within the healthy range. It has increased from 15.34 (Mar 23) to 18.76, marking an increase of 3.42.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 86.10. It has increased from 75.21 (Mar 23) to 86.10, marking an increase of 10.89.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 86.10. It has increased from 75.21 (Mar 23) to 86.10, marking an increase of 10.89.
• For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 170.01. It has increased from 152.96 (Mar 23) to 170.01, marking an increase of 17.05.
• For PBDIT / Share (Rs.), as of Mar 24, the value is 28.46. This value is within the healthy range. It has increased from 20.45 (Mar 23) to 28.46, marking an increase of 8.01.
• For PBIT / Share (Rs.), as of Mar 24, the value is 22.70. This value is within the healthy range. It has increased from 16.82 (Mar 23) to 22.70, marking an increase of 5.88.
• For PBT / Share (Rs.), as of Mar 24, the value is 17.92. This value is within the healthy range. It has increased from 15.41 (Mar 23) to 17.92, marking an increase of 2.51.
• For Net Profit / Share (Rs.), as of Mar 24, the value is 13.01. This value is within the healthy range. It has increased from 11.71 (Mar 23) to 13.01, marking an increase of 1.30.
• For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 13.01. This value is within the healthy range. It has increased from 11.70 (Mar 23) to 13.01, marking an increase of 1.31.
• For PBDIT Margin (%), as of Mar 24, the value is 16.73. This value is within the healthy range. It has increased from 13.36 (Mar 23) to 16.73, marking an increase of 3.37.
• For PBIT Margin (%), as of Mar 24, the value is 13.35. This value is within the healthy range. It has increased from 10.99 (Mar 23) to 13.35, marking an increase of 2.36.
• For PBT Margin (%), as of Mar 24, the value is 10.53. This value is within the healthy range. It has increased from 10.07 (Mar 23) to 10.53, marking an increase of 0.46.
• For Net Profit Margin (%), as of Mar 24, the value is 7.65. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 7.65.
• For NP After MI And SOA Margin (%), as of Mar 24, the value is 7.64. This value is below the healthy minimum of 8. It has decreased from 7.65 (Mar 23) to 7.64, marking a decrease of 0.01.
• For Return on Networth / Equity (%), as of Mar 24, the value is 15.12. This value is within the healthy range. It has decreased from 15.61 (Mar 23) to 15.12, marking a decrease of 0.49.
• For Return on Capital Employeed (%), as of Mar 24, the value is 10.60. This value is within the healthy range. It has decreased from 17.73 (Mar 23) to 10.60, marking a decrease of 7.13.
• For Return On Assets (%), as of Mar 24, the value is 4.34. This value is below the healthy minimum of 5. It has decreased from 8.13 (Mar 23) to 4.34, marking a decrease of 3.79.
• For Long Term Debt / Equity (X), as of Mar 24, the value is 1.16. This value exceeds the healthy maximum of 1. It has increased from 0.14 (Mar 23) to 1.16, marking an increase of 1.02.
• For Total Debt / Equity (X), as of Mar 24, the value is 1.48. This value exceeds the healthy maximum of 1. It has increased from 0.33 (Mar 23) to 1.48, marking an increase of 1.15.
• For Asset Turnover Ratio (%), as of Mar 24, the value is 0.76. It has decreased from 1.20 (Mar 23) to 0.76, marking a decrease of 0.44.
• For Current Ratio (X), as of Mar 24, the value is 1.07. This value is below the healthy minimum of 1.5. It has decreased from 1.09 (Mar 23) to 1.07, marking a decrease of 0.02.
• For Quick Ratio (X), as of Mar 24, the value is 0.75. This value is below the healthy minimum of 1. It has decreased from 0.77 (Mar 23) to 0.75, marking a decrease of 0.02.
• For Inventory Turnover Ratio (X), as of Mar 24, the value is 5.77. This value is within the healthy range. It has decreased from 8.00 (Mar 23) to 5.77, marking a decrease of 2.23.
• For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 42.28. This value is within the healthy range. It has decreased from 46.98 (Mar 23) to 42.28, marking a decrease of 4.70.
• For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 29.31. This value is within the healthy range. It has decreased from 35.88 (Mar 23) to 29.31, marking a decrease of 6.57.
• For Earning Retention Ratio (%), as of Mar 24, the value is 57.72. This value is within the healthy range. It has increased from 53.02 (Mar 23) to 57.72, marking an increase of 4.70.
• For Cash Earning Retention Ratio (%), as of Mar 24, the value is 70.69. This value exceeds the healthy maximum of 70. It has increased from 64.12 (Mar 23) to 70.69, marking an increase of 6.57.
• For Interest Coverage Ratio (X), as of Mar 24, the value is 5.94. This value is within the healthy range. It has decreased from 14.45 (Mar 23) to 5.94, marking a decrease of 8.51.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 3.72. This value is within the healthy range. It has decreased from 9.28 (Mar 23) to 3.72, marking a decrease of 5.56.
• For Enterprise Value (Cr.), as of Mar 24, the value is 14,557.51. It has increased from 5,237.43 (Mar 23) to 14,557.51, marking an increase of 9,320.08.
• For EV / Net Operating Revenue (X), as of Mar 24, the value is 2.27. This value is within the healthy range. It has increased from 0.90 (Mar 23) to 2.27, marking an increase of 1.37.
• For EV / EBITDA (X), as of Mar 24, the value is 13.55. This value is within the healthy range. It has increased from 6.79 (Mar 23) to 13.55, marking an increase of 6.76.
• For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 1.58. This value is within the healthy range. It has increased from 0.75 (Mar 23) to 1.58, marking an increase of 0.83.
• For Retention Ratios (%), as of Mar 24, the value is 57.71. This value is within the healthy range. It has increased from 53.01 (Mar 23) to 57.71, marking an increase of 4.70.
• For Price / BV (X), as of Mar 24, the value is 3.12. This value exceeds the healthy maximum of 3. It has increased from 1.55 (Mar 23) to 3.12, marking an increase of 1.57.
• For Price / Net Operating Revenue (X), as of Mar 24, the value is 1.58. This value is within the healthy range. It has increased from 0.75 (Mar 23) to 1.58, marking an increase of 0.83.
• For EarningsYield, as of Mar 24, the value is 0.04. This value is below the healthy minimum of 5. It has decreased from 0.10 (Mar 23) to 0.04, marking a decrease of 0.06.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness